160 related articles for article (PubMed ID: 19874245)
1. Hepatic veno-occlusive disease during chemotherapy for nephroblastoma: successful and safe treatment with defibrotide. Report of a clinical case.
Cecinati V; Giordano P; De Leonardis F; Grassi M; Arcamone G; De Mattia D; Santoro N
Immunopharmacol Immunotoxicol; 2009; 31(4):702-5. PubMed ID: 19874245
[TBL] [Abstract][Full Text] [Related]
2. Veno-occlusive disease in pediatric patients affected by Wilms tumor.
Cesaro S; Spiller M; Sartori MT; Alaggio R; Peruzzo M; Saggiorato G; Bisogno G
Pediatr Blood Cancer; 2011 Aug; 57(2):258-61. PubMed ID: 21246705
[TBL] [Abstract][Full Text] [Related]
3. Education and imaging. Hepatobiliary and pancreatic: sinusoidal obstruction syndrome during chemotherapy.
Menke J
J Gastroenterol Hepatol; 2011 Jun; 26(6):1083. PubMed ID: 21564291
[No Abstract] [Full Text] [Related]
4. Sinusoidal Obstruction Syndrome During Chemotherapy of Pediatric Cancers and its Successful Management With Defibrotide.
Kizilocak H; Dikme G; Özdemir N; Kuruğoğlu S; Adaletli İ; Erkan T; Celkan T
J Pediatr Hematol Oncol; 2017 Oct; 39(7):e373-e376. PubMed ID: 28859028
[TBL] [Abstract][Full Text] [Related]
5. Defibrotide for the treatment of hepatic veno-occlusive disease in children.
Bulley SR; Strahm B; Doyle J; Dupuis LL
Pediatr Blood Cancer; 2007 Jun; 48(7):700-4. PubMed ID: 16786586
[TBL] [Abstract][Full Text] [Related]
6. Defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome following nontransplant-associated chemotherapy: Final results from a post hoc analysis of data from an expanded-access program.
Kernan NA; Richardson PG; Smith AR; Triplett BM; Antin JH; Lehmann L; Messinger Y; Liang W; Hume R; Tappe W; Soiffer RJ; Grupp SA
Pediatr Blood Cancer; 2018 Oct; 65(10):e27269. PubMed ID: 29873895
[TBL] [Abstract][Full Text] [Related]
7. Complete resolution of transplantation-associated thrombotic microangiopathy and hepatic veno-occlusive disease by defibrotide and plasma exchange.
Beşişik SK; Oztürk GB; Calişkan Y; Sargin D
Turk J Gastroenterol; 2005 Mar; 16(1):34-7. PubMed ID: 16252186
[TBL] [Abstract][Full Text] [Related]
8. Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial.
Corbacioglu S; Cesaro S; Faraci M; Valteau-Couanet D; Gruhn B; Rovelli A; Boelens JJ; Hewitt A; Schrum J; Schulz AS; Müller I; Stein J; Wynn R; Greil J; Sykora KW; Matthes-Martin S; Führer M; O'Meara A; Toporski J; Sedlacek P; Schlegel PG; Ehlert K; Fasth A; Winiarski J; Arvidson J; Mauz-Körholz C; Ozsahin H; Schrauder A; Bader P; Massaro J; D'Agostino R; Hoyle M; Iacobelli M; Debatin KM; Peters C; Dini G
Lancet; 2012 Apr; 379(9823):1301-9. PubMed ID: 22364685
[TBL] [Abstract][Full Text] [Related]
9. Escalation to High-Dose Defibrotide in Patients with Hepatic Veno-Occlusive Disease.
Triplett BM; Kuttab HI; Kang G; Leung W
Biol Blood Marrow Transplant; 2015 Dec; 21(12):2148-2153. PubMed ID: 26278046
[TBL] [Abstract][Full Text] [Related]
10. High-dose methylprednisolone treatment of hepatic veno-occlusive disease in a child with Wilms tumor.
Akyüz C; CaClar K; Emir S; Büyükpamukçu M
Pediatr Hematol Oncol; 2003 Jun; 20(4):345-9. PubMed ID: 12746168
[TBL] [Abstract][Full Text] [Related]
11. Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease: Final Results From the International Compassionate-Use Program.
Corbacioglu S; Carreras E; Mohty M; Pagliuca A; Boelens JJ; Damaj G; Iacobelli M; Niederwieser D; Olavarría E; Suarez F; Ruutu T; Verdonck L; Hume R; Nejadnik B; Lai C; Finetto G; Richardson P
Biol Blood Marrow Transplant; 2016 Oct; 22(10):1874-1882. PubMed ID: 27397724
[TBL] [Abstract][Full Text] [Related]
12. Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.
Corbacioglu S; Kernan N; Lehmann L; Brochstein J; Revta C; Grupp S; Martin P; Richardson PG
Expert Rev Hematol; 2012 Jun; 5(3):291-302. PubMed ID: 22780209
[TBL] [Abstract][Full Text] [Related]
13. Late-onset hepatic veno-occlusive disease post autologous peripheral stem cell transplantation successfully treated with oral defibrotide.
Shah MS; Jeevangi NK; Joshi A; Khattry N
J Cancer Res Ther; 2009; 5(4):312-4. PubMed ID: 20160371
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment with defibrotide for sinusoidal obstruction syndrome after hematopoietic stem cell transplantation.
Yakushijin K; Matsui T; Okamura A; Yamamoto K; Ito M; Chihara K
Kobe J Med Sci; 2005; 51(3-4):55-65. PubMed ID: 16444097
[TBL] [Abstract][Full Text] [Related]
15. In brief: Defibrotide (Defitelio) for hepatic veno-occlusive disease.
Med Lett Drugs Ther; 2016 Sep; 58(1503):120. PubMed ID: 27603963
[No Abstract] [Full Text] [Related]
16. Successful defibrotide treatment of a patient with veno-occlusive disease after living-donor liver transplantation: A case report.
Lee TB; Yang K; Ko HJ; Shim JR; Choi BH; Lee JH; Ryu JH
Medicine (Baltimore); 2021 Jun; 100(25):e26463. PubMed ID: 34160449
[TBL] [Abstract][Full Text] [Related]
17. Gemtuzumab ozogamicin-induced sinusoidal obstructive syndrome treated with defibrotide: a case report.
Lannoy D; Decaudin B; Grozieux de Laguérenne A; Barrier F; Pignon JM; Wetterwald M; Odou P
J Clin Pharm Ther; 2006 Aug; 31(4):389-92. PubMed ID: 16882110
[TBL] [Abstract][Full Text] [Related]
18. Hepatopathy-thrombocytopenia syndrome after actinomycin-D therapy: treatment with defibrotide.
Martín-Lázaro JF; Palanca D; Garcia-Iñiguez JP; Madurga P; Carboné A
Pediatr Hematol Oncol; 2013 Feb; 30(1):25-7. PubMed ID: 23216129
[TBL] [Abstract][Full Text] [Related]
19. Late occurrence of hepatic veno-occlusive disease following gemtuzumab ozogamicin: successful treatment with defibrotide.
Saviola A; Luppi M; Potenza L; Morselli M; Ferrari A; Riva G; Torelli G
Br J Haematol; 2003 Nov; 123(4):752-3. PubMed ID: 14616990
[No Abstract] [Full Text] [Related]
20. Hepatic veno-occlusive disease in pediatric stem cell transplantation: impact of pre-emptive antithrombin III replacement and combined antithrombin III/defibrotide therapy.
Haussmann U; Fischer J; Eber S; Scherer F; Seger R; Gungor T
Haematologica; 2006 Jun; 91(6):795-800. PubMed ID: 16769582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
